Amantadine protects dopamine neurons by a dual action: Reducing activation of microglia and inducing expression of GNDF in astroglia
- 30 September 2011
- journal article
- research article
- Published by Elsevier BV in Neuropharmacology
- Vol. 61 (4), 574-582
- https://doi.org/10.1016/j.neuropharm.2011.04.030
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Quantification of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1/GluN2A NMDARsNeuropharmacology, 2011
- Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood‐brain barrier and MPTP‐induced dopaminergic toxicity in rodentsJournal of Neurochemistry, 2010
- Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar ratsBehavioural Brain Research, 2010
- Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial ActivationNeuropsychopharmacology, 2009
- NADPH oxidase as a therapeutic target in Alzheimer's diseaseBMC Neuroscience, 2008
- MemantineDrugs, 2006
- Mechanism of Inhibition of TRPC Cation Channels by 2-AminoethoxydiphenylboraneMolecular Pharmacology, 2005
- Amantadine for traumatic brain injury: does it improve cognition and reduce agitation?Journal of Clinical Pharmacy & Therapeutics, 2005
- Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson?s diseaseJournal of Neural Transmission, 2004
- MK‐801 Fails to Protect Against the Dopaminergic Neuropathology Produced by Systemic 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mice or Intranigral 1‐Methyl‐4‐Phenylpyridinium in RatsJournal of Neurochemistry, 1992